[Tickers Inside] 5 Solid Gainers Over the Last 5 Sessions

This is a must read. If you cannot see this email properly, please click [here]( [marketinside...] --------------------------------------------------------------- [A $226B Copper Spending Jackpot]( [See Who Can Benefit From this Government-backed Initiative.]([aff_i?offer_...] --------------------------------------------------------------- September 29, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 5 Five Day Gainers of all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- [Biden Warns America on China: "They're Going to Eat Our Lunch"]( [70c34788-d3c...](A new cold war over "white gold" is unfolding. This affects every cell phone, laptop... even tools in your home. But one small company is poised to break the Chinese stranglehold and reward savvy investors. [Find out what you need to know in this report.]( [5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [HeartBeam, BEAT]( Recent Analyst Action: Jason Kolbert, analyst at Dawson James, reiterates coverage on [HeartBeam (BEAT)](in the Healthcare sector with a Buy rating and a price target of $12.00 (2 months ago). - Recent Price: $4.12 - Average Analyst Price Target: $12.00 (191.26%) - Market Cap: $27.51M [TipRanks.com]( also reports that [HeartBeam](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $12.00. The target pricing ranges from a high forecast of $12.00 down to a low forecast of $12.00. [HeartBeam (BEAT)](’s last closing price was $4.12 which would put the average price target at $12.00. Here are 3rd party ratings for [BEAT](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 36% (91 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Get Expert Stock Recommendations for Just $1]( [ee906750-060...](See what some of the smartest minds in the financial world are buying today for just $1. Gains as high as 834%,1,315%, and 1,601% [already uncovered!](//trailer.web-view.net/Links/0XC897D7FB8E35C7125716691692541779279E75CDEA23DB78F4DB735A08F1DFC4296C4F3A1983C977CBCBD027793648FC21EEEBAA71B08176001B444F7491C4D0F598CD369566B7DD.htm [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Nuvalent, NUVL]( Recent Analyst Action: Etzer Darout, analyst at BMO Capital, reiterates coverage on [Nuvalent (NUVL)](in the Healthcare sector with a Buy rating and a price target of $28.00 (1 month ago). - Recent Price: $19.76 - Average Analyst Price Target: $28.00 (41.70%) - Market Cap: $953.74M [TipRanks.com]( also reports that [Nuvalent](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $28.00. The target pricing ranges from a high forecast of $28.00 down to a low forecast of $28.00. [Nuvalent (NUVL)](’s last closing price was $19.76 which would put the average price target at $28.00. Here are 3rd party ratings for [NUVL](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 32% (81 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast: ["Prepare for Five Years of Famine"]( [Screen+Shot+...]( [Click here]( for the name of the one ticker you need to protect yourself.[5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [Inari Medical, NARI]( Recent Analyst Action: Dev Weerasuriya, analyst at Berenberg Bank, reiterates coverage on [Inari Medical (NARI)](in the Healthcare sector with a Buy rating and a price target of $85.00 (14 hours ago). - Recent Price: $72.94 - Average Analyst Price Target: $93.17 (27.74%) - Market Cap: $3.90B [TipRanks.com]( also reports that [Inari Medical](currently has 6 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $93.17. The target pricing ranges from a high forecast of $100.00 down to a low forecast of $85.00. [Inari Medical (NARI)](’s last closing price was $72.94 which would put the average price target at $93.17. Here are 3rd party ratings for [NARI](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Bottom 39% (154 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Copper More Critical than Lithium]( [be7e813c-17c...](Lithium may have grabbed the headlines as a key material in building electric vehicles (EVs). But so is copper. And copper's importance in the new green economy goes far beyond EVs. Copper is critical in building wind turbines and solar panels. It's key to power lines and upgrading the national grid. Analysts say we're facing a 10-million-ton shortfall if new copper mines are not found. [See How You Can Benefit From New Copper Discoveries.]( [5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [Xoma, XOMA]( Recent Analyst Action: Joseph Pantginis, analyst at H.C. Wainwright, reiterates coverage on [Xoma (XOMA)](in the Healthcare sector with a Buy rating and a price target of $69.00 (1 month ago). - Recent Price: $17.876 - Average Analyst Price Target: $69.00 (286.00%) - Market Cap: $202.11M [TipRanks.com]( also reports that [Xoma](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $69.00. The target pricing ranges from a high forecast of $69.00 down to a low forecast of $69.00. [Xoma (XOMA)](’s last closing price was $17.876 which would put the average price target at $69.00. Here are 3rd party ratings for [XOMA](: - TipRanks.com: Moderate Buy - TradingView.com: Neutral - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Strong Sell, Top 32% (81 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Palantir Technologies, PLTR]( Recent Analyst Action: Kamil Mielczarek, analyst at William Blair, reiterates coverage on [Palantir Technologies (PLTR)](in the Technology sector with a Sell rating (1 week ago). - Recent Price: $7.94 - Average Analyst Price Target: $10.86 (36.78%) - Market Cap: $16.39B [TipRanks.com]( also reports that [Palantir Technologies](currently has 9 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $10.86. The target pricing ranges from a high forecast of $20.00 down to a low forecast of $6.00. [Palantir Technologies (PLTR)](’s last closing price was $7.94 which would put the average price target at $10.86. Here are 3rd party ratings for [PLTR](: - TipRanks.com: Hold - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Strong Sell, Bottom 39% (154 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Lithium Triangle a "Treasure Trove"for the Popular Energy Metal]( [4911c126-1cc...](Lithium is the most precious commodity of the green revolution, and experts predict an exploding demand for the energy metal. Surrounded by multi-billion dollar assets, one little-known small-cap company in a renowned location in South America may become a strong link in the lithium supply chain due to a monster acquisition. [Put this company on your radar now.]( [5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- And there you have it--5 Five Day Gainers of all US Exchanges. Sincerely, The Editor, MarketInsidersPress.com Market Insider Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. MarketInsidersPress.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane | Mooresville NC | 28115 MarketInsidersPress.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mount Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software